FENNEC PHARMACEUTICALS INC.

By person

13 insiders · 206 transactions

1.1×

Jeffrey Hackman holds only 1.1 times base salary in stock. $682.25K of shares against $586.34K in salary for 2025.

Salary from the company's own proxy. The shares are what Jeffrey Hackman last reported holding, valued at $10.29, the price Common Shares was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Southpoint Capital Advisors LP entity

10% owner

$500.00K (1)

$10.34M (7)

−$9.84M

6,821,955

19.45%

$70.20M

−15.5%

MANCHESTER MANAGEMENT PR, LLC entity

10% owner

$720.83K (48)

$10.35M (31)

−$9.63M

2,916,666

8.32%

$30.01M

−22.3%

Essetifin SPA

10% owner

$7.30M (2)

—

+$7.30M

3,993,694

11.39%

$41.10M

+36.2%

Raykov Rosty

Former Director

— (1)

$3.83M (44) scheduled

−$3.83M

124,411

0.3548%

$1.28M

+66.9%

Andrade Robert

CHIEF FINANCIAL OFFICER

— (1)

$1.94M (11) scheduled

−$1.94M

241,306

0.6881%

$2.48M

—

Haigh Adrian

CHIEF OPERATING OFFICER

—

$1.51M (10) scheduled

−$1.51M

0.0000%

$0.00

—

RALLIS CHRIS A

Director

—

$296.78K (18) scheduled

−$296.78K

63,077

0.1799%

$649.06K

—

Brughera Marco Maria

Director

—

$159.96K (1) scheduled

−$159.96K

0.0000%

$0.00

—

Sayad Pierre Sargis

Chief Medical Officer

—

$146.16K (1)

−$146.16K

9,519

0.0271%

$97.95K

—

Hackman Jeffrey S.

Chief Executive Officer

$104.60K (2)

—

+$104.60K

66,302

0.1891%

$682.25K

—

Islam Khalid

Director

—

213,825

0.6098%

$2.20M

—

Cioffi Christiana Marie

Chief Strategy Officer

—

24,644

0.0703%

$253.59K

—

Evans Terry L

Chief Commercial Officer

—

21,519

0.0614%

$221.43K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Brughera Marco Maria

15 Sep 2026

Director

Sold after exercise

15,545

$10.29

$159.96K

Raykov Rosty

1 Jul 2026

Former Director

Sold after exercise

9,599

$10.41

$99.93K

Raykov Rosty

1 Jun 2026

Director

Sold after exercise

9,747

$9.62

$93.77K

RALLIS CHRIS A

11 May 2026

Director

Sold after exercise

8,346

$7.04

$58.76K

Raykov Rosty

1 May 2026

Director

Sold after exercise

10,781

$6.47

$69.75K

Raykov Rosty

1 Apr 2026

Director

Sold after exercise

10,946

$6.31

$69.07K

Raykov Rosty

2 Mar 2026

Director

Sold after exercise

10,079

$8.36

$84.26K

Raykov Rosty

2 Feb 2026

Director

Sold after exercise

10,349

$7.76

$80.31K

Raykov Rosty

2 Jan 2026

Director

Sold after exercise

10,312

$7.60

$78.37K

RALLIS CHRIS A

10 Oct 2025

Director

Sold after exercise

1,775

$9.24

$16.40K

RALLIS CHRIS A

7 Jul 2025

Director

Sold after exercise

1,119

$8.71

$9.75K

RALLIS CHRIS A

11 Apr 2025

Director

Sold after exercise

1,409

$4.95

$6.97K

RALLIS CHRIS A

14 Feb 2025

Director

Sold after exercise

1,186

$6.82

$8.09K

RALLIS CHRIS A

2 Dec 2024

Director

Sold after exercise

6,409

$6.14

$39.35K

RALLIS CHRIS A

8 Oct 2024

Director

Sold after exercise

1,406

$4.53

$6.37K

RALLIS CHRIS A

5 Jul 2024

Director

Sold after exercise

1,173

$6.03

$7.07K

Haigh Adrian

22 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,223

$9.32

$207.03K

Haigh Adrian

19 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$9.34

$207.44K

Haigh Adrian

18 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$9.62

$213.78K

Haigh Adrian

18 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$2.31

$51.33K

Haigh Adrian

17 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$9.91

$220.22K

Haigh Adrian

17 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$2.31

$51.33K

Haigh Adrian

16 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$10.28

$228.39K

Haigh Adrian

16 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$2.31

$51.33K

RALLIS CHRIS A

15 Apr 2024

Director

Sold after exercise

800

$10.45

$8.36K

Haigh Adrian

15 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$10.30

$228.79K

Haigh Adrian

15 Apr 2024

CHIEF OPERATING OFFICER

Sold after exercise

22,222

$2.31

$51.33K

RALLIS CHRIS A

26 Mar 2024

Director

Sold after exercise

2,114

$10.97

$23.19K

Raykov Rosty

28 Dec 2023

CHIEF EXECUTIVE OFFICER

Sold after exercise

3,656

$11.55

$42.23K

RALLIS CHRIS A

26 Dec 2023

Director

Sold after exercise

1,390

$10.90

$15.15K

RALLIS CHRIS A

24 Jul 2023

Director

Sold after exercise

6,796

$8.17

$55.52K

RALLIS CHRIS A

6 Jul 2023

Director

Sold after exercise

2,207

$8.47

$18.69K

Andrade Robert

30 Jun 2023

CHIEF FINANCIAL OFFICER

Sold after exercise

7,500

$8.82

$66.15K

Show all 206 transactions →

FENNEC PHARMACEUTICALS INC.

By person

Individual transactions

What was left out